Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplant vasculopathy

M C Deng1, T D Tjan, B Asfour

  • 1Department of Cardiothoracic Surgery, Muenster University Hospital. deng@uni-muenster.de

Herz
|July 1, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Der neue Phosphodiesterasehemmer Enoximone: Einsatzmöglichkeiten im Rahmen herzchirurgischer Eingriffe.

Herz·2025
Same author

Retraction Note: Influence of cardiac output on thermal-dye extravascular lung water (EVLW) in cardiac patients.

Intensive care medicine·2023
Same author

[Off-label use in cardiac surgery].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2020
Same author

Towards an evidence based perspective in advanced heart failure care.

Zeitschrift fur Kardiologie·2016
Same author

Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation.

Surgical technology international·2015
Same author

[Not Available].

Zeitschrift fur Kardiologie·2014
Same journal

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026
Same journal

[Effects of air pollution on cardiovascular health].

Herz·2026
Same journal

[Heart and climate].

Herz·2026
Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026
Same journal

[Noise and the heart].

Herz·2026
Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026
See all related articles

Transplant vasculopathy, a key barrier in heart transplants, arises from the recipient's immune system attacking the donor blood vessels. This immune response triggers smooth muscle cell migration and proliferation, leading to vessel narrowing and graft failure.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Transplantation Medicine

Background:

  • Transplant vasculopathy is the primary cause of death in heart transplant recipients.
  • It is understood as an immune-mediated injury to the graft's vascular endothelium.

Purpose of the Study:

  • To elucidate the immunological mechanisms underlying transplant vasculopathy.
  • To detail the cellular and molecular events contributing to intimal hyperplasia in transplanted hearts.

Main Methods:

  • The study reviews the immune response following allogeneic heart transplantation.
  • It analyzes the roles of various immune cells and cytokines in graft injury.

Main Results:

  • Recipient immune cells (B-cells, T-helper1/2 cells, cytotoxic T-cells, macrophages, polymorphonuclear cells) orchestrate an attack on donor endothelium.

Related Experiment Videos

  • Cytokine signaling promotes donor smooth muscle cell migration and phenotypic switching.
  • Intimal smooth muscle cell proliferation, driven by immune cells and lipids, leads to fibroproliferative growth.

    • Conclusions:

    • Transplant vasculopathy results from a complex immune response targeting graft vascular endothelium.
    • Understanding these mechanisms is crucial for developing targeted therapies to improve long-term heart transplant survival.